Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials.

dc.contributor.authorDore, G. J.
dc.contributor.authorConway, B.
dc.contributor.authorLuo, Y.
dc.contributor.authorJanczewska, E.
dc.contributor.authorKnysz, B.
dc.contributor.authorLiu, Y.
dc.contributor.authorStreinu-Cercel, A.
dc.contributor.authorCaruntu, F. A.
dc.contributor.authorCurescu, M.
dc.contributor.authorSoza, Alejandro
dc.date.accessioned2021-05-13T17:51:13Z
dc.date.available2021-05-13T17:51:13Z
dc.date.issued2016
dc.fuente.origenConveris
dc.identifier.doi10.1016/j.jhep.2015.08.015
dc.identifier.eissn1600-0641
dc.identifier.issn0168-8278
dc.identifier.urihttps://doi.org/10.1016/j.jhep.2015.08.015
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/58305
dc.issue.numeroNo. 1
dc.nota.accesoContenido completo
dc.pagina.final28
dc.pagina.inicio19
dc.revistaJournal of Hepatologyes_ES
dc.rightsacceso abierto
dc.titleEfficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV. patients: The MALACHITE-I/II. trials.es_ES
dc.typeartículo
dc.volumenVol. 64
sipa.codpersvinculados461
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Efficacy and safety of ombitasvir-paritaprevir-r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients, The MALACHITE-I-II trials..pdf
Size:
944.45 KB
Format:
Adobe Portable Document Format
Description: